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Splice Variant of Mouse Stam2 mRNA in Nervous and Muscle Tissue 
Contains Additional Exon with Stop Codon within Region Codings for 
VHS Domain
Aim To analyze the alternatively spliced variant of Stam2 mRNA 
and determine its distribution in mouse tissues.
Methods We identified a novel alternatively spliced exon by cloning 
and sequencing of Stam2 cDNA obtained from tissue samples of 3-5 
months old male C57Bl/6NCrl mice. The sequence of the alterna-
tively spliced exon was analyzed by bioinformatic tools. The tissue 
distribution of different Stam2 mRNA variants was determined 
by reverse transcription-polymerase chain reaction, and the conse-
quences of the alternative splicing at the protein level were analyzed 
by western blot with the polyclonal anti-STAM2 antibody.
Results The novel alternatively spliced exon 1A of mouse Stam2 
gene was inserted within Stam2 coding region and it contained a 
stop codon. The exon did not bear similarities to any other cDNA 
or protein sequence in the mouse, rat, or human databases. Both 
mRNA variants, with and without exon 1A, were present in the 
cortex, hippocampus, olfactory bulb, medulla oblongata, spinal 
cord, cerebellum, and the skeletal and heart muscle, while the other 
analyzed organs contained only the variant without the additional 
exon. The mRNA with the included exon did not give rise to a pro-
tein form detectable by western blotting with the polyclonal anti-
STAM2 antibody.
Conclusion The alternatively spliced exon 1A was included in 
mRNA splice variant present in the nervous and muscle tissues. The 
alternative splicing event did not have major impact on STAM2 
production and functionality. It seems that exon 1A is an evolution-
ary new exon created by exonization of an intronic sequence.
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Membrane traffic is a dynamic process re-
sponsible for the maintenance of diverse cellular 
activities, including stress response, down-regu-
lation of cell-surface molecules, and signal trans-
duction. Molecules on the cell surface, together 
with those from outside the cell, could be inter-
nalized into the early endosome and subsequent-
ly either recycled back to the cell surface or de-
graded via multivesicular bodies (MVB) in the 
lysosome (1,2). The selection of the right cargo 
toward these two different pathways is not com-
pletely understood, but monoubiquitination and 
deubiquitination processes could play an impor-
tant role (3).
Signal-transducing adaptor molecules 1 and 2 
(STAM1 and STAM2) are proteins sharing 55% 
of protein sequence and considered to play a role 
in the endosomal sorting of the ubiquitinated 
cargo proteins (4,5). They form a ternary com-
plex with hepatocyte growth factor-regulated 
tyrosine kinase substrate (HRS) and epidermal 
growth factor receptor pathway substrate clone 
No. 15 (EPS15) (6). The complex is located at 
the cytosolic side of the endosome and it sorts 
ubiquitinated membrane proteins into the clath-
rin-coated microdomains, thereby preventing 
their recycling to the cell surface (6,7). STAM 
proteins possess Vps-27/HRS/STAM (VHS) 
and ubiquitin-interacting motif (UIM) domains 
that are involved in ubiquitin binding (5). VHS 
domain is a conserved region, found exclusively 
at the N-terminus of proteins and therefore its 
topology is considered relevant for its function 
(8,9).
Alternative mRNA splicing is a regulated 
process of differential inclusion or exclusion of 
regions of the pre-mRNA and is a major source 
of protein diversity in higher eukaryotes (10). Al-
ternative splicing is widespread in eukaryotic ge-
nomes and more than 60% of all human genes 
have alternatively spliced variants (11). It plays 
important roles not only in human physiology 
and disease, but also in evolution by increasing 
the rate of evolutionary alterations, such as exon 
creation (12).
Our aim was to analyze the newly identified 
alternatively spliced exon 1A included within 
VHS region of Stam2 gene and determine its dis-
tribution, because it has been questioned if the 
alternatively spliced variant influences STAM2 




We used the inbred mouse strain C57Bl/
6NCrl and transgenic mouse line Stam2Gt1Gaj in 
our investigation. All experiments except west-
ern blotting were performed on 3-5-month-old 
male C57Bl/6NCrl mice. Five mice were used to 
search for additional alternatively spliced exons 
of Stam2 by reverse transcription-polymerase 
chain reaction (RT-PCR) and three mice were 
used to determine the tissue distribution of exon 
1A and the presence of exon 1B. For the west-
ern blot, one male C57Bl/6NCrl mouse and one 
male Stam2Gt1Gaj mouse were used. Stam2Gt1Gaj 
mice were generated by gene trap method based 
on random insertion of nonhomologous DNA 
vector pKC199βgeo in the genome of embryon-
ic stem cells at the Max Planck Institute for Bio-
physical Chemistry in Göttingen, Germany (13). 
The inserted gene trap vector contained the splice 
acceptor sequence from mouse Hoxc9 gene fused 
to promoterless βgeo, which is lacZ-NeoR fusion 
gene (14). The transgene insertion was in Stam2 
gene, within intron between exons 2 and 3. It in-
terfered with the further Stam2 mRNA tran-
scription after the insertion site. The Stam2Gt1Gaj 
mouse line was kept on C57Bl/6NCrl genetic 
background through 16 generations. Genotyping 
of transgenic animals was performed by PCR on 
tail DNA. Homozygous animals were obtained 
by intercrosses of heterozygotes.
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Reverse transcriptase-polymerase chain 
reaction, cloning, and sequencing
Total RNA was isolated from organs of adult 
C57Bl/6NCrl mice. The animals were killed by 
cervical dislocation. Approximately 100 mg of 18 
different tissues (cortex, hippocampus, olfacto-
ry bulb, medulla oblongata, spinal cord, cerebel-
lum, heart, lungs, thymus, spleen, liver, pancreas, 
kidney, suprarenal gland, testis, muscle, bone and 
abdominal adipose tissue) of 3 C57Bl/6NCrl 
mice was isolated, frozen in liquid nitrogen and 
homogenized in 1 mL of cold TRI REAGENT 
solution (MRC Inc. Cincinnati, OH, USA) by 
tissue homogenizer (Ultra-turrax T25, Janke & 
Kunkel IKA Labortechnik, Staufen, Germany). 
The RNA was isolated according to the manu-
facturer’s instructions and dissolved in diethyl-
pyrocarbonate (DEPC)-treated water.
First-strand cDNA synthesis was performed 
from 1-2 µg total RNA with 200 U of reverse 
transcriptase (Moloney Murine Leukemia Vi-
rus Reverse Transcriptase RNase H-, Promega, 
Madison, WI, USA), 15 U RNasin Plus RNase 
Inhibitor (Promega), 200 ng oligonucleotide 
primer specific for Stam2 (5′ TAAACAGCA-
CACCCACAAAG 3′), and 0.5 mmol/L de-
oxynucleotide triphosphates (Promega) in 25-µL 
reaction mix.
Polymerase chain reactions (50 µL volume) 
were carried out using 1 U of DNA polymerase 
(Taq DNA Polymerase; Promega), 0.2 mmol/L 
deoxynucleotide triphosphates, and 20 pmol of 
each primer in a PCR machine GeneAmp PCR 
System 2400 (Applied Biosystems, Foster City, 
CA, USA). The amplified products were electro-
phoresed on a 1.8%-agarose gel and visualized by 
ethidium bromide, using 100-bp DNA ladder 
(Promega) to estimate the band sizes. Five brain 
cDNA samples from 5 C57Bl/6NCrl mice were 
used for 40 RT-PCR reactions with different 
primer combinations covering the complete cod-
ing sequence of Stam2 (Figure 1A). The samples 
of the different tissues from 3 C57Bl/6NCrl 
mice were tested by RT-PCR to determine the 
presence of exons 1A and 1B. The primers were: 
A1 (5′ GCCAGAGCGTCGGGATTCAG 
3′), A2 (5′ GAGTGCTTCCAACCCTGTCA 
3′), A3 (5′ GAAAAGCGCTCTCCCACTCT 
3′), A4 (5′ AAGCTCGTGTTTCCCTGAGA 
3′) and A5 (5′ CCATGGAGGAGATTCAT-
GCT 3′) (Figure 1A).
The selected products generated by PCRs 
were cloned into a plasmid (pGEM-T Vector 
System I; Promega), amplified and sequenced in 
the sequencing machine Dye Terminator Cy-
cle Sequencing Ready Reaction with Amplitaq 
DNA Polymerase using ABI PRISM 377 DNA 
Sequencer (Applied Biosystems).
Western blot analysis
Tissue homogenates were prepared from the 
brain, liver, and heart of a C57Bl/6NCrl mouse 
and a Stam2Gt1Gaj mouse in the lysis buffer (150 
mmol/L NaCl, 50 mmol/L Tris · Cl, pH 8.0), 
1% Igepal (Sigma, St. Louis, MO, USA), and 2x 
Protease Inhibitor Coctail Complete (Roche, 
Basel, Switzerland) by tissue homogenizer Ultra-
turrax T25 (Janke & Kunkel IKA Labortech-
nik). The equivalent amounts of the protein from 
the tissue homogenates were run on 10%-sodium 
dodecyl sulfate polyacrylamide gel electrophore-
sis (SDS-PAGE) and electroblotted to nitrocel-
lulose membranes (Protran BA 85, Schleicher & 
Schuell, Dassel, Germany). The membranes were 
blocked for 1 hour with blocking buffer (Tris 
buffer saline, 0.1% Tween 20, and 5% milk pow-
der) and incubated for 2 hours with a polyclonal 
antibody against mouse STAM2 (1:500 dilu-
tion in blocking buffer) (15). Subsequently, blots 
were incubated with Antirabbit HRP (Promega) 
secondary antibody for 1 hour (1:2500 dilution). 
Bound antibodies were detected by TMB Stabi-
lized Substrate (Promega) peroxidase substrate.
Bioinformatics
The alternatively spliced exon nucleotide se-
quence was compared with nucleotide sequence 
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databases Homo sapiens LATESTGP database, 
Mus musculus LATESTGP database and Rat-
tus norvegicus LATESTGP database by En-
sembl Genome Browser (www.ensembl.org) and 
to nonredundant nucleotide sequence data-
base, GenBank+EMBL+DDBJ mouse, human, 
non-mouse and non-human EST databases and 
PDB nucleotide database by BLASTN program 
(www.ncbi.nlm.nih.gov/BLAST/). The results 
were confirmed by UCSC Genome Browser and 
BLAT Search Genome (http://genome.ucsc.edu/). 
Additional alternatively spliced exons in Stam2 
were also searched by UCSC Genome Brows-
er (http://genome.ucsc.edu/). The nucleotide se-
quences were translated to protein sequences by 
ExPASy Translate tool (www.expasy.ch/tools) 
and compared with non-redundant GeneBank 
CDS, non-redundant SwissProt sequences, and 
PDB protein database by BLASTP program 
(www.ncbi.nlm.nih.gov/BLAST/).
Results
Exon 1A is a novel alternatively spliced exon 
of Stam2 gene
Among RT-PCRs done on cDNA obtained 
from the mouse brain with primers specific for 
Stam2, different primer pairs resulted in the 
product of expected size and the additional 200-
base pairs longer product (Figure 1A). The same 
difference in size obtained by different prim-
Figure 1. Diagram of genomic Stam2 DNA and the coding region of Stam2 mRNA with alternatively spliced exon 1A and hypothetical exon 
1B between the first two exons. A. The start and stop codons are indicated on the genomic DNA. The exons’ numbers are above them. 
The lines above the mRNA represent the products of reverse transcriptase-polymerase chain reaction (RT-PCR), checked for alternatively 
spliced exons. Of a total of 40 reactions, 8 are depicted. Lines containing a portion of discontinued line corresponding to exon 1A represent 
two products: with and without exon 1A included. The lines below the mRNA show the position of primers (A1, A2, and A3) and fragments 
amplified by RT-PCR used for determination of the alternatively spliced mRNA tissue distribution. Primers A4 and A5 specific for the 
hypothetical exon 1B are also depicted. B. Nucleotide sequence of exons 1, 1A, and 2. Exon 1A is located between exons 1 and 2 and its 
sequence is underlined. The start codon ATG in exon 1 and the stop codon TAA in exon 1A are marked.
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er pairs indicated that the longer product could 
represent an alternative splicing event. The PCR 
products were cloned and sequenced, and the se-
quence obtained corresponded to those of Stam2 
cDNA including the additional novel fragment 
of 189 nucleotides (Figure 1B; GenBank ac-
cession number: DQ141211). The fragment 
matched a part of the intron sequence between 
Stam2 exons 1 and 2 from the bases 52668294 to 
52668482 of the mouse chromosome 2. There-
fore, it was referred to as Stam2 exon 1A.
To confirm that exon 1A represents an alter-
natively spliced exon in the mouse Stam2 gene, 
PCRs with the genomic DNA and the brain 
cDNA were performed. Primer pairs spanning 
exons 1 and 2, exons 1 and 1A, and exons 1A and 
2 never yielded any product in the reactions with 
the genomic DNA, whereas the expected prod-
uct sizes were obtained with the cDNA samples. 
This proved that newly identified exon 1A corre-
sponded to the alternatively spliced Stam2 exon.
There were no matches of exon 1A to any se-
quence in mouse cDNA databases, except a sin-
gle match corresponding to an intron sequence 
from genomic DNA (ie, part of Stam2 intron), 
assumed to be assigned by mistake as a cDNA 
(GenBank accession number: CA569372). 
In addition, a search of mouse, rat and human 
cDNA and protein databases showed that there 
was no other sequence similar to Stam2 exon 1A 
in mouse, rat and human cDNA, suggesting that 
the alternatively spliced exon 1A is unique for 
mouse, ie, it is not evolutionary conserved. The 
comparison of mouse Stam2 exon 1A sequence 
to genomic DNA of mouse, rat and human re-
vealed 88.6% identity between Stam2 exon 1A 
and a fragment of the rat chromosome 3 from 
base 34149796 to 34149973 residing in the in-
tron between the first two exons of the predict-
ed rat Stam2 gene (GenBank accession number: 
NM001012085.1). Nevertheless, this similar-
ity was comparable to that of the whole corre-
sponding Stam2 intron (88.3%), implying that it 
only reflected the general similarity of the rat and 
mouse genomes. No similarity with human ge-
nomic DNA was found.
Stam2 mRNA splice variant with exon 1A 
included is present in the nervous and muscle 
tissue
To determine the tissue distribution of exon 
1A in mouse, the RT-PCRs were performed on 
RNA samples from 18 different mouse tissues 
and organs. Three primers, A1, A2, and A3, spe-
cific for exons 1, 2, and 1A, respectively, were 
used in the same reaction set (Figures 1A and 
2). Three products were expected as follows: the 
shorter product resulting from the primers in ex-
ons 1 and 2 (A1/A2) corresponding to exon 1A 
exclusion, the longer product resulting from the 
same primers corresponding to exon 1A inclu-
sion, and the product of the intermediate size, re-
sulting from the primers in exons 1A and 2 (A2/
Figure 2. Distribution of the alternatively spliced Stam2 mRNA 
with exon 1A in mouse tissues determined by reverse transcrip-
tase-polymerase chain reaction (RT-PCR). A 155-bp band (from 
primer A1 to A2) represents the mRNA form without exon 1A 
(constitutive form), and 245-bp (from primer A3 to A2) and 334-
bp (from primer A1 to A2) fragments represent the mRNA form 
with exon 1A included (alternatively spliced form). The alterna-
tively spliced form was present in nervous and muscle tissues. 
The bands of 245 bp and 334 bp in the heart and skeletal muscle 
are shown very weakly. The bands representing the constitutive 
Stam2 mRNA are stronger than bands representing alternatively 
spliced transcript. The band of approximately 100 bp visible in 
some samples represents an unspecific PCR product. Primers 
are shown in Figure 1A.
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A3), specific for the mRNA with exon 1A (Fig-
ures 1A and 2). All three products were present 
in the samples from the nervous system (cortex, 
hippocampus, olfactory bulb, medulla oblonga-
ta, spinal cord, and cerebellum) and those from 
the skeletal and heart muscle, showing that both 
splice variants were present in these samples. 
Only a single product corresponding to the ex-
clusion of exon 1A was present in the lungs, thy-
mus, spleen, liver, pancreas, kidney, suprarenal 
gland, testis, bone and abdominal adipose tissue 
(Figure 2). Although RT-PCR is not a quanti-
tative method, the intensities of the obtained 
bands indicated that the mRNA without exon 
1A was more abundant than the mRNA with 
exon 1A included.
Exon 1A is a unique alternatively spliced exon 
in Stam2 gene
To test if there were additional alternatively 
spliced exons of Stam2, 40 different RT-PCRs 
with primers covering the complete coding se-
quence of Stam2 were performed on mouse 
brain cDNA (Figure 1A). The RT-PCR dem-
onstrated that there was no other alternatively 
spliced exon, except exon 1A, in the coding re-
gion of Stam2 cDNA obtained from the mouse 
brain. It was also shown that a transcript con-
taining exon 1A contained all 14 Stam2 exons.
The USCS Genome Browser revealed many 
cDNA clones from different mouse tissues or cell 
cultures matching Stam2 only intron sequence. 
However, only a single clone (GenBank acces-
sion number: AW647621), beside matching the 
intron sequence, included the relevant neighbor-
ing exon sequence, indicating that it could repre-
sent an alternatively spliced Stam2 cDNA. The 
AW647621 clone was generated from the differ-
entiated murine adipose 3T3 cell line. The hypo-
thetical additional exon was referred to as Stam2 
exon 1B. Its sequence was located in the same in-
tron as exon 1A, between Stam2 exons 1 and 2, 
which is the longest Stam2 intron (Figure 1A).
To check if exon 1B was present in the 
cDNA of different mouse tissues, we performed 
RT-PCRs with primers spanning Stam2 exons 1 
and 2 (primers A1/A2), exons 1 and 1B (primers 
A1/A4), and exons 1B and 2 (primers A5/A2) 
(Figure 1A). Exon 1B was not detected in any 
tissue tested, including the abdominal adipose 
tissue. These results indicated that exon 1A was a 
unique alternatively spliced exon in Stam2 gene.
Only STAM2 protein corresponding to the 
mRNA without exon 1A was detected by 
western blot
The translation of exon 1A nucleotide se-
quence into the protein sequence revealed stop 
codons in all three reading frames, particularly 
the UAA stop codon in the open reading frame 
of Stam2 (Figure 1B). Therefore, the coding re-
gion of the transcript containing alternative 
exon 1A was only 162 nucleotides long and cor-
responded to 53 aminoacids. This short protein 
would share with STAM2 only 13 aminoacids at 
its N-terminus, hence the transcript containing 
exon 1A would not contribute to a protein with 
STAM2 function.
To test if the alternatively spliced mRNA 
variant gave rise to a protein sharing, the func-
tional domains with STAM2 protein despite the 
presence of the stop codon, or if the hypotheti-
cal 53 aminoacids protein interfered with the 
Figure 3. Western blot analysis showing a single form of STAM2 
protein in the brain, liver, and heart of the wild type mouse. Aste-
rixes indicate the expected positions of the presumed products of 
the alternatively spliced Stam2 mRNA. The predicted molecular 
weight of the alternative splice forms of STAM2 is either 5 kDa 
higher (with stop codon readtrough), or 6 kDa lower than the major 
form of STAM2 (without readtrough, but with translation start from 
the first following ATG signal). Protein samples from the brain, 
liver, and heart tissue of Stam2Gt1Gaj homozygous mutant mouse 
with impaired STAM2 protein production served as a negative 
control.
Croat Med J 2006;47:16-24
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normal STAM2 production, western blot anal-
ysis with polyclonal anti-STAM2 antibody was 
performed on samples from the brain and heart, 
expressing the both mRNA variants, and the 
liver, expressing only the mRNA variant with-
out exon 1A (Figure 3). To distinguish specific 
from unspecific binding of the used polyclonal 
antibody against STAM2, the wild type mice 
were compared to the mutant Stam2Gt1Gaj mice, 
where Stam2 was modified by gene trap (13). 
Due to the vector insertion, the production of 
STAM2 protein in the homozygous Stam2Gt1Gaj 
mutants was strongly impaired. Western blot 
analysis showed a single specific band of 67 kDa 
present in all samples of the wild type mouse, cor-
responding to the STAM2 protein without exon 
1A inclusion. No specific bands corresponding 
to the presumed products of the alternatively 
spliced mRNA or to their degradation products 
were detected. In addition, there was no differ-
ence in the intensities of the other weaker bands 
observed when the samples from wild type and 
mutant mouse were compared, showing that the 
other bands were unspecific (Figure 3). These re-
sults indicated that the inclusion of exon 1A did 
not result in a protein sharing the functional do-
mains with STAM2, neither did it interfere with 
STAM2 protein production.
Discussion
A Stam2 transcript containing a newly iden-
tified exon 1A was sequenced and characterized 
by use of bioinformatics, RT-PCR and western 
blot. This transcript was present in the nervous 
and muscle tissue together with the previously 
known transcript without exon 1A, and it was 
absent from all other tested tissues. Moreover, no 
other additional Stam2 transcripts were detect-
ed, which indicated that Stam2 transcription re-
sulted in a single constitutive mRNA form pres-
ent in all adult tissues and another, less abundant, 
alternatively spliced form, which includes exon 
1A present only in the subset of the tissues.
The alternatively spliced exon 1A identified 
in Stam2 gene corresponded to a mouse specif-
ic intron sequence that was spliced as an exon. 
It seems that the appearance of the alternatively 
spliced transcript is a recent evolutionary event 
since exon 1A is not evolutionary conserved and 
is present only in the alternatively spliced tran-
script form (16,17). Likewise, the exons included 
only in the alternative splice forms (as opposed 
to the constitutive or major transcript form) are 
usually not conserved (12,18). The lack of simi-
lar sequence in the mouse genome and the pres-
ence of the similar sequence in the correspond-
ing intron of the hypothetical rat Stam2 implies 
that exon 1A appeared by direct recruitment of 
the intron sequence but not by insertion of a se-
quence originating from a different part of the 
genome (19,20). The recruitment of intronic se-
quences as new alternatively spliced exons was 
proposed to have an important role in evolution-
ary emergence of new protein sequences in eu-
karyotes (12,16,19,21).
It was questionable if the appearance of the 
new exon in the alternatively spliced transcript 
resulted in a new function. We speculated that it 
may have resulted in a modified STAM2 protein 
or influenced the production of STAM2 pro-
tein in the nervous and muscle tissues. The inser-
tion of exon 1A near the STAM2 N-terminus, 
within the region coding for the VHS domain, 
would certainly influence this domain. More-
over, as exon 1A contained the stop codon, the 
presumed result of the translation was a short 
53-aminoacids long protein lacking all STAM2 
functional domains.
Splicing of transcripts into unproductive 
mRNAs, which could be targeted for degrada-
tion, represents a possible mechanism to regulate 
gene expression (22). For example, a point muta-
tion in Alu element residing in the third intron 
of ornithine aminotransferase gene activates a 
cryptic splice site and consequently leads to the 
introduction of an incomplete Alu element into 
an open reading frame (23). The in-frame stop 
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codon carried by Alu element results in a trun-
cated protein and ornithine aminotransferase de-
ficiency. In the same way, the production of the 
described splice variant of Stam2 could represent 
an option to be used by splicing machinery to 
regulate the expression of Stam2 depending on 
the ratio of the exon inclusion.
There was also a possibility that a changed, 
but functional, STAM2 protein form was pro-
duced from the alternatively spliced mRNA 
containing the UAA codon by a phenomenon 
called readthrough, although a readtrough at 
UAA codon has shown to be less effective than 
at UGA and UAG codons (24). In case that the 
stop codon would not be recognized, the result-
ing protein would have VHS domain disturbed, 
but other protein domains would be preserved. 
The same would be achieved if the cryptic ATG 
translation start after the stop codon would be 
used. Nevertheless, western blot analysis with 
polyclonal anti-STAM2 antibody showed no 
other protein form except regular STAM2 pro-
tein. Therefore, it seemed that the alternative 
splicing did not have an impact on the STAM2 
production or function. Since the evolution of 
new coding sequences from noncoding ones is 
an active ongoing process in eukaryotes, it is pos-
sible that creation of exon 1A is just a recent at-
tempt of evolution to regulate Stam2 function 
(19). The considered possibilities highlight the 
versatility of the splicing mechanisms in achiev-
ing various tasks, which can either occur sponta-
neously and be selected by evolution, or be arti-
ficially designed and used for experimental and 
therapeutic purposes.
In conclusion, alternatively spliced exon 1A 
was included in mRNA splice variant present in 
the nervous and the muscle tissues, but the al-
ternative splicing did not have a major impact 
on STAM2 production and functionality. The 
facts that exon 1A represented a mouse intron 
sequence containing the stop codon, which was 
unique in mouse genome and not evolutionary 
conserved, and which was present only in the al-
ternatively spliced transcript form in a subset of 
mouse tissues, implied that exon 1A is evolution-
ary new exon created by exonization of intronic 
sequence.
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